Editorial

» immunology and culture

Most Recent

image: Nosing Around

Nosing Around

By | November 1, 2016

Covering neuroscience research means choosing from an embarrassment of riches.

0 Comments

image: Stubbornly Persistent

Stubbornly Persistent

By | February 1, 2015

Microorganisms continually challenge our assumptions of what life can achieve.

1 Comment

image: A Chill Issue

A Chill Issue

By | February 1, 2013

The very cold, the merely chilled, and the colorful

0 Comments

image: In the Long Run

In the Long Run

By | December 1, 2012

Can emulating our early human ancestors make us healthier?

1 Comment

image: Meeting of the Minds

Meeting of the Minds

By | July 1, 2012

New changes at The Scientist will ensure that we continue to showcase the best and brightest ideas in the life sciences.

1 Comment

image: Avant-Garde Science

Avant-Garde Science

By | June 1, 2012

Why naked mole-rats and experimental gene therapies remind me of groundbreaking artists.

0 Comments

image: Alive and Kicking

Alive and Kicking

By | October 1, 2011

The publication I launched a quarter century ago has come further than anyone ever expected.

27 Comments

image: A Shot in the Arm

A Shot in the Arm

By | June 1, 2011

Decades of vaccine research have expanded our understanding of the immune system and are yielding novel disease-fighting tactics.

0 Comments

Popular Now

  1. UC Berkeley Receives CRISPR Patent in Europe
    Daily News UC Berkeley Receives CRISPR Patent in Europe

    The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.

  2. DNA Replication Errors Contribute to Cancer Risk
  3. Should Healthy People Have Their Exomes Sequenced?
    Daily News Should Healthy People Have Their Exomes Sequenced?

    With its announced launch of a whole-exome sequencing service for apparently healthy individuals, Ambry Genetics is the latest company to enter this growing market. But whether these services are useful for most people remains up for debate.  

  4. Rethinking a Cancer Drug Target
    Daily News Rethinking a Cancer Drug Target

    The results of a CRISPR-Cas9 study suggest that MELK—a protein thought to play a critical role in cancer—is not necessary for cancer cell survival.

Business Birmingham